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Purpose: To present a patient with overlapping choriocapillaritis syndromes who 
first presented as a typical case of multiple evanescent white dot syndrome (MEWDS) 
and later with characteristic findings compatible with multifocal choroiditis (MFC).
Case Report: A 40-year-old myopic woman presented with a paracentral scotoma OS. 
Fundus examination revealed pale discolored areas around the optic disc corresponding 
to faintly hyperfluorescent areas on fluorescein angiography (FA). On indocyanine 
green angiography (ICGA) there was extensive peripapillary hypofluorescence 
and confluent hypofluorescent dots superiorly. According to the clinical picture, 
a diagnosis of MEWDS was made. In 4 weeks, the visual field reverted to normal 
together with almost complete regression of hypofluorescence on ICGA. However, 
4 months later fundus examination revealed some scars, a finding not typical for 
MEWDS. Besides, she developed another scotoma 12 months later accompanied by 
photopsia and the fundus illustrated more numerous scars than one year earlier. 
ICGA showed hypofluorescent areas corresponding to the scotoma delineated by 
visual field testing. The pattern of this recurrence clearly corresponded to MFC.
Conclusion: This case illustrates an overlap between two entities, MEWDS and 
MFC in two sequential episodes. FA and fundus autofluorescence accounted for the 
lesions and optical coherence tomography showed damage to the photoreceptor outer 
segments, but only ICGA correlated well with functional evolution.
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INTRODUCTION
Primary inflammatory choriocapillaropathies 
(PICCPs) are a group of disorders characterized 
by choriocapillaritis causing sectoral non-
perfusion of the choriocapillaris.1 They comprise 
most of the diseases formerly classified within 
the umbrella term “white dot syndromes”,2 
including multiple evanescent white dot 
syndrome (MEWDS), acute posterior multifocal 
placoid pigment epitheliopathy (APMPPE), 
multifocal choroiditis (MFC), serpiginous 
choroiditis (SC) and some rare entities. The 
most appropriate technique to investigate 
these entities is indocyanine green angiography 
(ICGA) which shows diverse patterns of 
hypofluorescence indicating choriocapillaris 
hypo or non-perfusion which is the common Overlapping Choriocapillaritis Syndromes; Kuznetsova et al
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denominator of these diseases.3-6 The disease 
mechanism had already been suspected well 
before the availability of ICGA and findings 
based on this imaging modality only confirmed 
the suspected pathophysiology for this group of 
disorders.7 The consequence of choriocapillaris 
non-perfusion is outer retinal ischemia with 
damage to the photoreceptor outer segment 
layer (POSL).8 The extent of hypofluorescent 
non-perfusion and the degree of associated 
ischemia determine the severity of each entity; 
MEWDS is on the benign end of the spectrum 
while serpiginous choroiditis which entails 
irreversible chorioretinal atrophy lies at the 
more severe end.9 Intermediate forms of 
choroicapillaritis such as ampiginous choroiditis 
or relentless placoid choroiditis have been 
described with characteristics of APMPPE and 
serpiginous choroiditis (SC).10,11 More recently, 
choriocapillaritis with positive interferon-
gamma release assays which manifests with 
mixed features of APMPPE and SC has been 
termed multifocal-serpiginous choroiditis.12,13 
Unclassifiable forms that cannot be categorized 
under one of the well-determined entities have 
also been reported.14 Moreover, several cases 
have been published in which the patient 
presented with one choriocapillaritis syndrome 
at a time but with features consistent with 
another entity at another time.15-18 Herein, we 
present a case of overlapping choriocapillaritis 
syndromes; the patient was first diagnosed with 
MEWDS but demonstrated typical findings 
corresponding to multifocal choroiditis a 
year later. Analysis of the morphologic and 
pathophysiologic features of both inflammatory 
episodes could be achieved thanks to multimodal 
imaging including fundus examination/
photography, fluorescein angiography (FA), 
ICGA, fundus autofluorescence (FAF) and 
optical coherence tomography (OCT). Functional 
parameters including visual field testing and 
microperimetry facilitated the diagnosis and 
management.
CASE REPORT 
A 40-year-old myopic female presented with 
a paracentral scotoma OS of about one week’s 
duration. Her past ocular history revealed high 
bilateral myopia of 11.75 diopters (D) in the right 
eye (OD) and 10.0 D in the left eye (OS). She 
Figure 1. Evolution of the visual field defect during the first episode of choriocapillaritis diagnosed as multiple evanescent 
white dot syndrome (MEWDS) and the second episode characterized as multifocal choroiditis. The peripapillary defect 
at presentation (left column) corresponded to indocyanine green angiography (ICGA) hypofluorescence (figure 4) and 
resolved without treatment (second and third columns) after the first choriocapillaritis episode diagnosed as MEWDS. 
Sixteen months later, a similar visual field defect again corresponding to ICGA hypofluorescence (figure 7) developed 
during a second episode of choriocapillaritis (fourth column) and progressed over a period of 4 days (second column 
from the right) but resolved (right column) one month after a sub-Tenon’s injection of triamcinolone in parallel with 
resolution of ICGA hypofluorescence.Overlapping Choriocapillaritis Syndromes; Kuznetsova et al
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had been operated for rhegmatogenous retinal 
detachment in her right eye 15 years earlier 
and 360 degrees circumferential prophylactic 
argon laser treatment had been performed 
for both eyes. Two years before the current 
episode, cataract surgery had been performed 
followed by Nd:YAG laser capsulotomy in 
both eyes a few months later. To treat residual 
astigmatism, an arcuate corneal incision had 
been performed in the left eye a few months 
following cataract surgery.
Upon presentation, best corrected visual 
acuity (BCVA) was 0.9 and 0.8 in the right and 
left eyes, respectively. No signs of inflammation 
were detected in the anterior chambers, but laser 
flare photometry (LFP) values were slightly 
elevated; up to 9.5 ph/ms OD and 13.2 ph/ms 
OS (normal values: 3-6 ph/ms). There were no 
cells visible in the vitreous. Visual field testing 
using the Octopus Perimeter® (Haag-Streit, 
Bern, Switzerland) showed a peripapillary 
scotoma OS (Fig. 1) and a normal visual field OD. 
Microperimetry displayed slightly diminished 
retinal sensitivity OS with a test score of 390/560 
versus 414/560 OD.
Fundus examination showed pale discolored 
dots around the optic disc and along the 
superior temporal arcade OS (Fig. 2a) which 
corresponded to faintly hyperfluorescent areas 
on FA (Fig. 3a). More precise information on 
the diseased areas was revealed by ICGA: there 
was extensive peripapillary hypofluorescence 
extending inferiorly together with centripetal 
hypofluorescent dots along the superior 
temporal arcade (Fig. 4a). These areas were 
precisely delineated by FAF, showing hyper-
autofluorescence corresponding to ICGA 
hypofluorescent areas (Fig. 5a). Spectral 
domain OCT imaging (Heidelberg Instruments, 
Heidelberg, Germany) clearly showed POSL 
damage in scans through ICGA hypofluorescent 
and FAF hyper-autofluorescent areas, which 
Figure 2. Fundus images at presentation (2a), after 1 month (2b), and at 4 months (2c). Faint discolored peripapillary 
fundus lesions typical of multiple evanescent white dot syndrome (MEWDS) were seen at presentation (2a) and 
still present after one month (2b); corresponding to fluorescein angiography (FA) hyperfluorescent areas and 
hyperautofluorescent areas. At 4 months (2c), these lesions take the aspect of chorioretinal scars while FA and 
hyperautofluorescent lesions are no longer present.
Figure 3. Fluorescein angiography at presentation (3a), after 1 month (3b), and at 4 months (3c). Patchy hyperfluorescent 
areas were seen at presentation around the optic disc and along the temporal superior arcade (3a) and were still present 
at 1 month (3b), but resolved after 4 months (3c).Overlapping Choriocapillaritis Syndromes; Kuznetsova et al
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also corresponded to the visual field defect. The 
whole POSL was damaged on scans through the 
ICGA hypofluorescent area (Fig. 6a; arrows), 
but damage was partial in bordering areas 
(Figures 6b and 6c; arrows).
Four weeks later, discolored lesions were 
still visible in the fundus (Fig. 2b), FA and FAF 
illustrated a few scattered new lesions (Figures 3b 
and 5b), but on ICGA the hypofluorescence 
had regressed almost completely and this was 
related with visual field recovery (Figures 4b 
and 1; second column from the left).
Four months later, fundus examination 
showed scars in areas where lesions had been 
present, a finding not typical of MEWDS 
(Fig.  2c). These scars were also seen on FA 
frames in the form of late hyperfluorescent 
dots (Fig. 3c) as well as on ICGA frames in the 
form of hypofluorescent dots (Fig. 4c). Along the 
superior temporal arcade, FA hyperfluorescent 
areas had disappeared (Fig. 3c) and on FAF a 
normal homogeneous aspect was seen (Fig. 5c). 
Twelve months after the last follow-up (16 
months after the first episode), the patient was 
seen again for the same subjective scotoma in her 
left eye accompanied by photopsias. BCVA was 
1.0 OD and 0.9 OS. No inflammation was noted 
in the anterior chamber or in the vitreous. LFP 
values were 6.0 ph/ms OD and 8.9 ph/ ms OS, 
showing slight subclinical flare OS. Intraocular 
pressure was 14 mmHg bilaterally. On fundus 
examination peripapillary and superior nasal 
scars were more numerous than 12 months 
earlier (Fig. 7a). Octopus® perimetry showed 
a peripapillary scotoma similar to the one seen 
during the prior presentation which increased 4 
days later (Fig. 1; third and second columns from 
the right); the microperimetry score declined 
Figure 4. Indocyanine green angiography at presentation (4a), after 1 month (4b), and at 4 months (4c). Confluent 
peripapillary hypofluorescence and scattered hypofluorescent areas are seen superiorly at presentation (4a), which 
almost completely resolved after one month (4b). However at 4 months (4c), hypofluorescent pinpoints are seen 
indicating chorioretinal scars.
Figure 5.  Fundus autofluorescence pictures at 
presentation (5a), after 1 month (5b), and at 4 months (5c). 
On the right column (left eye), hyper-autofluorescent 
areas corresponding to FA and ICGA lesions can be 
seen at presentation (5a) which, on the middle picture, 
slightly progressed after one month (5b) with return to 
normal at 4 months (5c).Overlapping Choriocapillaritis Syndromes; Kuznetsova et al
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again to 338/560 as during the first episode. On 
FA there were less intensely hyperfluorescent 
zones indicating more atrophic areas than acutely 
involved retina (Fig. 7c). FAF did not show the 
intense hyper-autofluorescence seen during the 
first episode (Fig. 7b). Only ICGA accounted 
for the functional impairment recorded by 
visual field testing and microperimetry, and 
allowed to identify the involved areas showing 
hypofluorescence precisely corresponding to the 
scotoma (Fig. 7d). The hypofluorescent ICGA 
areas also corresponded to POSL damage 
(Fig.  8a; arrows). The disease pattern seen 
with this recurrence clearly corresponded to 
multifocal choroiditis, therefore a sub-Tenon 
injection of triamcinolone acetonide (40 mg) was 
performed considering progression of visual 
field defects after 4 days and due to the fact that 
unlike MEWDS, multifocal choroiditis produces 
scars and carries a high risk of inflammatory 
choroidal neovascular membranes.
One month after the sub-Tenon’s 
triamcinolone injection OS, the diffuse 
peripapillary hypofluorescence recovered on 
ICGA where only small hypofluorescent dots 
representing previous chorioretinal scars were 
still visible (Fig. 7e) and corresponded to POSL 
reconstitution (Fig. 8b) as well as visual field 
recovery (Fig. 1, right column). In parallel, 
microperimetry improved from 328/560 to 
424/560. Regular follow-up including ICGA was 
decided for the patient, as occult choriocapillaritis 
can occur in the absence of any signs except for 
ICGA hypofluorescence.
DISCUSSION
Multiple evanescent white dot syndrome, 
first described by Lee Jampol et al in 1984, 
predominantly affects young to middle-aged 
women; the condition causes unilateral visual 
loss of variable degrees (severe in some cases) 
and scotomas objectively identified by visual 
field testing.19-21 Characteristic symptoms include 
photopsia usually reported spontaneously by 
the patient. The disease usually hits only once 
and the condition is self limited and favorable 
with restoration of visual function within 6 
to 12 weeks. Funduscopy reveals numerous 
faint white dots in the mid-periphery at the 
onset of the disease. These dots can disappear 
rapidly and may be missed by the clinician if 
the patient does not present at an early stage; 
in this case ICGA is especially valuable in 
reaching a diagnosis.6,22 ICGA shows numerous 
hypofluorescent dark areas predominantly in 
Figure 6.  Optical coherence tomography scans at 
presentation through ICGA hypofluorescent areas (6a), 
and at the border of ICGA hypofluorescent area (6b 
and 6c).  The top set of figures (6a) represents a scan 
going through the ICGA hypofluorescent area showing 
damaged photoreceptor outer segment layer (POSL) 
with clumps throughout the whole scan. 6b and 6c 
show scans at the border of the ICGA hypofluorescent 
demonstrating sectoral damage to POSL (arrows).Overlapping Choriocapillaritis Syndromes; Kuznetsova et al
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the mid-periphery and around the optic disc 
where the hypofluorescence is confluent.8,22 
Interestingly, these dark areas are faint in 
early and intermediate angiographic phases 
but become much more clearly delineated 
in the late phase, reflecting choriocapillaris 
hypo- rather than strict non-perfusion, which 
probably explains the usually favorable outcome 
of MEWDS without treatment. ICGA lesions 
almost integrally resolve spontaneously in the 
convalescent stage of the disease after 6-12 
weeks of evolution. ICGA is the most precise 
method to monitor disease evolution.1 
Multifocal choroiditis (MFC) occurs in the 
same age group as the other PICCPs, namely 
young to middle aged adults with women being 
predominantly affected.23 Lesions tend to leave 
scars and most of them are not spontaneously 
reversible, but active lesions seem to respond to 
inflammation suppressive therapy. Photopsia is 
more frequent than in MEWDS and it may be 
present even when there is no clinical evidence of 
reactivation. The patients also report scotomas. 
Multifocal choroiditis can be uni- or bilateral with 
usually asymmetric involvement.24 Perimetry 
objectively verifies the scotomas reported by 
the patient. On fundus examination, the typical 
lesions are small randomly distributed yellow-
white atrophic chorioretinal foci in the posterior 
pole and mid-periphery as well as the periphery. 
In the active episodes, new lesions are rarely 
visible on fundus examination and can be very 
discreet or absent on FA, whereas ICGA is the 
most sensitive method to detect such occult new 
lesions.1,25 One particular feature of multifocal 
choroiditis is the high proportion of neovascular 
membranes complicating the disease.23
ICGA reveals two sets of signs in 
MFC. The first type of signs identifies old 
scarred chorioretinal lesions and consists of 
hypofluorescent areas persisting up to the late 
phase, distributed randomly in the fundus, 
Figure 7. Second episode of choriocapillaritis consistent with multifocal choroiditis. Fundus images (7a) show 
chorioretinal scars nasal to the optic disc. Both fundus autofluorescence (7b) and fluorescein angiography (7c) show 
only faint lesions, while on indocyanine green angiography, hypofluorescence is substantial (7d), but resolves one 
month after periocular triamcinolone injection (7e) in parallel with recovery of the visual field (see figure 1).Overlapping Choriocapillaritis Syndromes; Kuznetsova et al
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corresponding to hyperfluorescent dots on late 
FA frames, typical for chorioretinal atrophy from 
scars of previous inflammatory episodes seen on 
fundus examination. The second type of signs 
can be seen along with previously described 
signs when choroiditis recurs. They consist of 
hypofluorescent areas, almost silent on FA and 
not visible on fundus examination, representing 
areas of new inflammatory involvement. As in 
MEWDS, some cases of MFC may manifest 
peripapillary hypofluorescence translating 
functionally into an enlarged blind spot.24 The 
Figure 8. Spectral domain OCT showing scans going through ICGA hypofluorescent area during acute (8a) and 
convalescent (8b) stages of the disease. During the acute stage (8a) there is damage to the photoreceptor outer segment 
layer (POSL) showing clumps of photoreceptor outer segments (arrows) in ICGA hypofluorescent areas. During the 
convalescent stage (8b) regeneration of the POSL (arrows) is noted.Overlapping Choriocapillaritis Syndromes; Kuznetsova et al
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latter signs respond to systemic corticosteroids 
and/or immunosuppression and can regress 
completely if therapy is started early. 
Both MEWDS and MFC preferentially affect 
myopic eyes and have a common denominator, 
choriocapillaritis.26 It is therefore not astonishing 
that overlap may exist between different entities 
under the PICCPs described in the past.14-16 
Our patient initially presented with typical 
features of MEWDS. However, four months 
after the initial episode of choriocapillaritis, 
chorioretinal scars appeared which is not typical 
of MEWDS. Thanks to multimodal imaging, the 
suspected pathophysiologic disease mechanism 
could be demonstrated morphologically; ICGA 
revealed choriocapillaris non-perfusion and 
spectral domain OCT scans through ICGA 
hypofluorescent areas demonstrated damage to 
POSL, a consequence of outer retina ischemia 
which is oxygenated through the choriocapillaris. 
FAF showed hyper-autofluorescence in the 
same ICGA hypofluorescent areas which is 
interpreted to be due to loss of photoreceptor 
outer segments27. The investigational modality 
that was best correlated with function (visual 
fields) was ICGA, since FA and FAF signs 
regressed later as compared to ICGA signs.
The second episode of choriocapillaritis 
could not be considered as MEWDS any more 
since this disease, by definition, occurs only once. 
Furthermore, additional chorioretinal scars had 
developed in the meantime, possibly due to silent 
episodes of choriocapillaritis. The clinical picture 
seen during the second symptomatic episode 
of choriocapillaritis corresponded to MFC. The 
pathophysiologic process was identical to the 
first episode, showing ICGA non-perfusion and 
POSL damage which both resolved one month 
following sub-Tenon’s triamcinolone injection, 
in parallel to visual field recovery.
It was important to identify the evolution 
from one PICCP, i.e. MEWDS, to another, 
i.e. MFC, because the course of MFC can be 
deleterious and recurrences, best identified by 
ICGA, have to be managed with inflammation 
suppressive therapy.
It is however possible that at initial 
presentation, the patient was already 
experiencing her first episode of MFC, 
although it resolved without therapy. The 
practical attitude to be drawn from this case is, 
whenever choriocapillaritis/PICCP is suspected, 
it is important to be aware of the underlying 
disease mechanism, namely choriocapillaris 
non-perfusion with outer retinal ischemia at the 
origin of this group of diseases. An attempt has 
to be made to classify each case under one of the 
well-known clinical entities including MEWDS, 
APMPPE, MFC or serpiginous choroiditis. This 
however may not be possible, as there are mixed 
forms, overlapping forms and unclassifiable 
forms. Therefore, all PICCPs should be followed 
with ICGA monitoring of choriocapillaris non-
perfusion in symptomatic patients. In case of 
recurrent ICGA hypofluorescence or persistent 
hypofluorescence in conjunction with functional 
impairment, inflammation suppressive therapy 
should be given and evolution monitored using 
ICGA. 
The case described herein demonstrated 
that FA was less precise than ICGA to delineate 
the diseased choriocapillaris especially during 
the second episode. FAF was useful during the 
first episode showing subclinical involvement, 
but showed almost no hyper-autofluorescence 
during the second inflammatory episode. 
Spectral domain OCT was helpful in delineating 
lesion morphology in the outer retina explaining 
functional loss. However, none of these imaging 
modalities were as closely correlated with 
functional parameters (visual fields) as ICGA, 
which represents the best imaging modality to 
monitor disease evolution.
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